Skip to main content
HANGZHOU AGS MEDTECH CO.,LTD logo

HANGZHOU AGS MEDTECH CO.,LTD — Investor Relations & Filings

Ticker · 688581 ISIN · CNE100005ZF0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2023-06-06 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688581

About HANGZHOU AGS MEDTECH CO.,LTD

http://www.bioags.com/en/index.aspx

Hangzhou AGS MedTech Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical instruments, primarily focusing on endoscopic accessories. The product portfolio encompasses a comprehensive range of disposable devices for gastrointestinal and respiratory interventions, including biopsy forceps, hemoclips, injection needles, polypectomy snares, and guide wires. The company integrates advanced manufacturing processes with rigorous quality management systems, adhering to international standards such as ISO 13485, CE, and FDA. By providing high-precision diagnostic and therapeutic tools, the organization supports clinical procedures in gastroenterology and pulmonology. Its technical expertise facilitates the delivery of reliable solutions aimed at improving procedural outcomes and patient safety in global healthcare markets.

Recent filings

Filing Released Lang Actions
安杰思独立董事关于第二届董事会第五次会议相关议案的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors providing prior approval opinions related to a board meeting agenda item about the renewal of the annual audit firm for 2023. It references regulatory rules and the company's articles of association. The content is about governance and board-level approval rather than the audit report itself or the annual report. The document length is short (431 characters), and it does not contain financial data or audit results. Therefore, it is best classified as Board/Management Information (MANG), which covers announcements related to board decisions and management matters.
2023-06-06 Chinese
安杰思首次公开发行股票科创板上市公告书提示性公告
Regulatory Filings Classification · 95% confidence The document is titled as a "首次公开发行股票科创板上市公告书提示性公告" which translates to "Initial Public Offering (IPO) Sci-Tech Innovation Board Listing Announcement Notice." It contains details about the company's stock code, total shares after IPO, risk warnings related to the IPO and stock trading, and contact information for the issuer and sponsor. The document is an announcement regarding the company's IPO and listing on the Shanghai Stock Exchange Sci-Tech Innovation Board, rather than the actual IPO prospectus or financial report. The document length is 3381 characters, which is relatively short and consistent with an announcement rather than a full report. It also states that the full prospectus and listing announcement are available on the exchange website, indicating this document is a notice or announcement. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the IPO listing, not the full prospectus or financial report itself.
2023-05-17 Chinese
安杰思公司章程
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association, containing chapters on general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, senior management, supervisory board, financial accounting system, profit distribution, audit, notices and announcements, mergers, splits, capital increases and decreases, dissolution and liquidation, and amendments to the articles. It includes detailed rules on shareholder rights, meeting procedures, voting, and corporate governance. There is no indication that this is an annual report, earnings release, or any financial statement. It is not a proxy statement or voting results announcement. It is a governance document outlining the internal rules and structure of the company. Therefore, the most appropriate classification is Governance Information (CGR). The document length is substantial and contains the full text of the governance rules, not just an announcement or summary.
2023-05-17 Chinese
安杰思首次公开发行股票科创板上市公告书
Capital/Financing Update Classification · 95% confidence The document is titled as a "首次公开发行股票科创板上市公告书" which translates to "Initial Public Offering (IPO) and Listing Announcement on the Science and Technology Innovation Board." It contains detailed information about the company's IPO, stock issuance, listing date, share distribution, risk factors related to the IPO, regulatory approvals from the China Securities Regulatory Commission and Shanghai Stock Exchange, and other related disclosures. The document is lengthy (15,000 characters) and contains substantive content about the IPO and listing process, including financial data and risk disclosures. It is not a simple announcement of a report but a comprehensive IPO listing announcement document. This type of document fits best under the category of Capital/Financing Update (CAP), as it relates to the company's fundraising and capital structure changes through the IPO and listing on the stock exchange.
2023-05-17 Chinese
安杰思首次公开发行股票并在科创板上市招股说明书提示性公告
Regulatory Filings Classification · 95% confidence The document is titled as a "招股说明书提示性公告" which translates to "Prospectus Indicative Announcement" for the initial public offering (IPO) and listing on the STAR Market (科创板) of Hangzhou Anjiesi Medical Technology Co., Ltd. It includes details about the stock issuance, share price, underwriting, and regulatory approvals from the China Securities Regulatory Commission (CSRC) and Shanghai Stock Exchange. The document is an announcement related to the IPO prospectus rather than the full prospectus itself or a detailed financial report. The length is relatively short (2634 characters), and it primarily serves to notify the public about the availability and key points of the prospectus. Therefore, it fits best into the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories like Capital/Financing Update or Share Issue/Capital Change, since it is not a direct announcement of share issuance but a notice about the prospectus publication.
2023-05-15 Chinese
安杰思首次公开发行股票并在科创板上市招股说明书
Capital/Financing Update Classification · 95% confidence The document is titled as a 招股说明书 (Prospectus) for the initial public offering (IPO) and listing on the STAR Market (科创板) of the Shanghai Stock Exchange. It contains detailed information about the company, the offering, risk factors, financial data, governance, and other disclosures typical of an IPO prospectus. It is not an announcement or a brief summary but a comprehensive document of about 15,000 characters. This type of document is a regulatory filing related to capital raising and listing, specifically a prospectus for a new share issuance. According to the filing definitions, this fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. It is not an Annual Report, Earnings Release, or other categories. Therefore, the correct classification is CAP with high confidence.
2023-05-15 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.